Compare LIF & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIF | SRRK |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.6B |
| IPO Year | N/A | 2018 |
| Metric | LIF | SRRK |
|---|---|---|
| Price | $56.96 | $45.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $91.93 | $49.80 |
| AVG Volume (30 Days) | 803.8K | ★ 995.0K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $459,031,000.00 | N/A |
| Revenue This Year | $30.95 | N/A |
| Revenue Next Year | $31.65 | $20,320.92 |
| P/E Ratio | $157.55 | ★ N/A |
| Revenue Growth | ★ 33.86 | N/A |
| 52 Week Low | $29.62 | $22.71 |
| 52 Week High | $112.54 | $48.28 |
| Indicator | LIF | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 27.37 | 54.94 |
| Support Level | $61.05 | $40.63 |
| Resistance Level | $66.30 | $46.75 |
| Average True Range (ATR) | 2.33 | 2.29 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 0.79 | 70.78 |
Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.